These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27061506)

  • 1. We Use Bioincompatible Peritoneal Dialysis Solutions.
    Troidle L; Hansson J; Juergensen P; Finkelstein FO
    Semin Dial; 2016 Jul; 29(4):263-4. PubMed ID: 27061506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combination of biocompatible peritoneal dialysis solutions and residual renal function, peritoneal transport, and inflammation markers: a randomized clinical trial.
    Lui SL; Yung S; Yim A; Wong KM; Tong KL; Wong KS; Li CS; Au TC; Lo WK; Ho YW; Ng F; Tang C; Chan TM
    Am J Kidney Dis; 2012 Dec; 60(6):966-75. PubMed ID: 22835900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Trio Trial - A Randomized Controlled Clinical Trial Evaluating the Effect of a Biocompatible Peritoneal Dialysis Solution on Residual Renal Function.
    Sikaneta T; Wu G; Abdolell M; Ng A; Mahdavi S; Svendrovski A; Tu T; Mercer T; Tong M; Oreopoulos D; Tam P
    Perit Dial Int; 2016 9-10; 36(5):526-32. PubMed ID: 27282852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocompatible peritoneal dialysis solutions: do we have one?
    Chaudhary K; Khanna R
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):723-32. PubMed ID: 20093342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocompatibility of peritoneal dialysis fluid and influence of compositions on peritoneal fibrosis.
    Higuchi C; Nishimura H; Sanaka T
    Ther Apher Dial; 2006 Aug; 10(4):372-9. PubMed ID: 16911191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Biocompatible" Neutral pH Low-GDP Peritoneal Dialysis Solutions: Much Ado About Nothing?
    Misra PS; Nessim SJ; Perl J
    Semin Dial; 2017 Mar; 30(2):164-173. PubMed ID: 28251697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Neutral-pH, Low-Glucose Degradation Product Peritoneal Dialysis Solutions on Residual Renal Function, Urine Volume, and Ultrafiltration: A Systematic Review and Meta-Analysis.
    Yohanna S; Alkatheeri AM; Brimble SK; McCormick B; Iansavitchous A; Blake PG; Jain AK
    Clin J Am Soc Nephrol; 2015 Aug; 10(8):1380-8. PubMed ID: 26048890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of neutral-pH, low-glucose degradation product peritoneal dialysis solutions compared with standard solutions: a secondary analysis of the balANZ Trial.
    Howard K; Hayes A; Cho Y; Cass A; Clarke M; Johnson DW
    Am J Kidney Dis; 2015 May; 65(5):773-9. PubMed ID: 25746151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newer peritoneal dialysis solutions.
    Gokal R
    Adv Ren Replace Ther; 2000 Oct; 7(4):302-9. PubMed ID: 11073562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
    Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F;
    BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of the clinical and biochemical profile of peritoneal dialysis fluid low in glucose degradation products.
    Lai KN; Lam MF; Leung JC; Chan LY; Lam CW; Chan IH; Chan HW; Li CS; Wong SS; Ho YW; Cheuk A; Tong MK; Tang SC
    Perit Dial Int; 2012; 32(3):280-91. PubMed ID: 22045098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for Biocompatible Peritoneal Dialysis Solutions.
    Nataatmadja M; Cho Y; Johnson DW
    Contrib Nephrol; 2017; 189():91-101. PubMed ID: 27951555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
    Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane.
    Williams JD; Topley N; Craig KJ; Mackenzie RK; Pischetsrieder M; Lage C; Passlick-Deetjen J;
    Kidney Int; 2004 Jul; 66(1):408-18. PubMed ID: 15200450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there such a thing as biocompatible peritoneal dialysis fluid?
    Schmitt CP; Aufricht C
    Pediatr Nephrol; 2017 Oct; 32(10):1835-1843. PubMed ID: 27722783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of neutral pH and low-glucose degradation product-containing peritoneal dialysis solution on residual renal function in peritoneal dialysis patients: a meta-analysis.
    Wang J; Zhu N; Yuan W
    Nephron; 2015; 129(3):155-63. PubMed ID: 25765060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of acid-base regulation in peritoneal dialysis.
    Sow A; Morelle J; Hautem N; Bettoni C; Wagner CA; Devuyst O
    Nephrol Dial Transplant; 2018 May; 33(5):864-873. PubMed ID: 29186492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal dialysis and inflammation.
    Velloso MS; Otoni A; de Paula Sabino A; de Castro WV; Pinto SW; Marinho MA; Rios DR
    Clin Chim Acta; 2014 Mar; 430():109-14. PubMed ID: 24333488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products--a 1-year randomized control trial.
    Szeto CC; Chow KM; Lam CW; Leung CB; Kwan BC; Chung KY; Law MC; Li PK
    Nephrol Dial Transplant; 2007 Feb; 22(2):552-9. PubMed ID: 17005526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low GDP Solution and Glucose-Sparing Strategies for Peritoneal Dialysis.
    Szeto CC; Johnson DW
    Semin Nephrol; 2017 Jan; 37(1):30-42. PubMed ID: 28153193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.